Paracetamol-induced acute liver failure: Prevention and management

Journal of Hepatology, Supplement

Volumn 26, Issue 1, 1997, Pages 41-46

  O'Grady, John G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; PARACETAMOL;

CHEMICALLY INDUCED DISORDER; EXTRACORPOREAL CIRCULATION; HEPATIC ENCEPHALOPATHY; HUMAN; INTOXICATION; LIVER FAILURE; LIVER TRANSPLANTATION; REVIEW;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; EXTRACORPOREAL CIRCULATION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; OVERDOSE;

EID: 0030633207     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(97)82332-x     Document Type: Article

References (45)

1. Fagan E, Wannan G. Reducing paracetamol overdoses. Br Med J 1996; 313: 1417-8.
2. Bray GP, Harrison PM, O'Grady JG, Tredger JM, Williams R. Long term anticonvulsant therapy worsens outcome in paracetamol induced fulminant hepatic failure. Hum Exp Toxicol 1992; 11: 265-70.
3. Mitchell JR. Acetaminophen toxicity. N Engl J Med 1988; 319: 1601-2.
4. Zimmerman HJ, Maddrey HJ. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology 1995; 22: 767-73.
5. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272: 1845-50.
6. Davis M. Protective agents for acetaminophen overdose. Semin Liver Dis 1986; 6: 138-47.
7. Laskin DL, Gardner CR, Price VFD, Jollow DJ. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 1995; 21: 1045-50.
8. Makin AJ, Wendon J, Williams R. A 7-year experience of severe paracetamol-induced hepatotoxicity (1987-1993). Gastroenterology 1995; 109: 1907-16.
9. Office of Population Consensuses and Surveys. Mortality Statistics: Accidents and Violence. London: HMSO, 1991.
10. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. Br Med J 1979; 2: 1097-100.
11. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-92.
12. Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJM, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br Med J 1991; 303: 1026-9.
13. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 1988; 319: 1557-62.
14. Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995; 21: 240-52.
15. Forbes A, Alexander GJM, O'Grady JG, Keays R, Gullan R, Dawling S, Williams R. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989; 10: 306-10.
16. Ede RJ, Gimson AES, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986; 2: 43-51.
17. Davenport A, Will EJ, Davison AM. Effect of posture on intracranial pressure and cerebral perfusion in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning. Crit Care Med 1990; 18: 286-9.
18. Cordoba J, Blei AT. Cerebral edema and intracranial pressure monitoring. Liver Transplant Surg 1995; 3: 187-94.
19. Rolando N, Harvey FAH, Brahm J, Philpott-Howard J, Alexcander GJM, Gimson AES, Casewell M, Fagan EA, Williams R. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990; 11: 49-53.
20. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201.
21. Rolando N, Wade JJ, Stangou A, Gimson AES, Wendon J, Philpott-Howard J, Casewell MW, Williams R. Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transplant Surg 1996; 2: 8-13.
22. Wendon JA, Harrison PM, Keays R, Gimson AE, Alexander GJM, Williams R. The effects of vasopressor agents and prostacyclin on systemic haemodynamics and oxygen transport in patients with fulminant hepatic failure. Hepatology 1992; 15: 1067-71.
23. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by N-acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1853-7.
24. Davenport A, Will EJ, Davison AM. Continuous vs intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema. Contrib Nephrol 1991; 93: 225-33.
25. Sette H, Hughes RD, Langley PG, Gimson AES, Williams R. Heparin response and clearance in acute and chronic liver disease. Thromb Haemostas 1985; 54: 591-4.
26. Langley PG, Keays R, Hughes RD, Forbes A, Delvos U, Williams R. Antithrombin III supplementation reduces heparin requirement and platelet loss during hemodialysis of patients with fulminant hepatic failure. Hepatology 1991; 14: 251-6.
27. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 1994; 66: 431-7.
28. O'Grady JG, Langley PG, Isola LM, Aledort AM, Williams R. Coagulopathy of fulminant hepatic failure. Semin Liver Dis 1986; 6: 159-63.
29. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
30. O'Grady JG, Wendon J, Tan KC, Potter D, Cottam S, Cohen AT, Gimson AES, Williams R. Liver transplantation after paracetamol overdose. Br Med J 1991; 303: 221-3.
31. Mirza DF, Mohamed R, Mutimer DJ, McMaster P. Timing and candidacy for transplantation in acute liver failure: the European experience. Liver Transplant Surg 1995; 1: 182-6.
32. Mutimer DJ, Ayres RCS, Neuberger JM, Davies MH, Holguin J, Buckels JA, Mayer AD, McMaster P, Elias E. Serious paracetamol poisoning and the results of liver transplantation. Gut 1994; 35: 809-14.
33. Detre K, Belle S, Beringer K, Daily OP. Liver transplantation for fulminant hepatic failure in the United States: October 1987 through December 1991. Clin Transplantation 1994; 8: 274-80.
34. Aldersley M, Juniper M, Richardson P, Howdle PD, O'Grady JG. Inability of intracranial pressure monitoring to select patients with acute liver failure for transplantation. Hepatology 1995; 22: 208A.
35. Schafrer DF, Shaw BW. Fulminant hepatic failure and orthotopic liver transplantation. Semin Liver Dis 1989; 9: 189-94.
36. Ascher NL, Lake JHR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg 1993; 128: 677-82.
37. Davies MH, Mutimer D, Lowes J, Elias E, Neuberger J. Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet 1994; 343: 1329-30.
38. Wendon J, Williams R. Acute liver failure. In: Williams R, Portmann B, Tan K-C, eds. The Practice of Liver Transplantation. London: Churchill-Livingstone, 1995: 93-103.
39. Husberg BS, Goldstein RM, Klintmalm GB, Gonwa T, Ramsay M, Cofer J, Solomon H, Watemberg I. A totally failing liver may be more harmful than no liver at all: three cases of total hepatic devascularisation in preparation for emergency liver tranplantation. Trans Proc 1991; 23: 1533-5.
40. Ringe B, Lubbe N, Kuse E, Frei U, Pichlmayr R. Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg 1993; 218: 3-9.
41. Pereira SP, McCarthy M, Ellis AJ, Wendon J, Rela M, Heaton N, Williams R. Auxiliary partial orthotopic liver transplantation for acute liver failure. Gut 1996; 38: A633.
42. Shaw BW. Auxiliary liver transplantation for acute liver failure. Liver Transplant Surg 1995; 1: 194-200.
43. Sussman NL, Gislason G, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994; 18: 390-6.
44. Demetriou AA, Rozga J, Podesta E, Lepage E, Morsiani E, Moscioni AD, Hoffman A, McGrath M, Kong L, Rosen H, Villamil F, Woolf G, Vierling J, Makowka L. Early clinical experience with a hybrid bioartificial liver. Scand J Gastroenterol 1995; 30: 111-7.
45. Ellis AJ, Wendon J, Hughes R, Dunne J, Langley PG, Kelly JH, Gislason GD, Sussman NL, Williams R. The extracorporeal liver assist device in acute liver failure: Design and testing of a controlled trial protocol. Hepatology 1996; 24: 1446-51.